[Advanced age--a risk factor in autologous blood donation?]

Area of Science:

• Gerontology
• Transfusion Medicine
• Hematology

Background:

• Autologous blood donation is a common practice for elective surgeries.
• Limited data exists on the tolerance of autologous blood donation in elderly populations (66-75 years).
• Assessing safety and physiological responses in this demographic is crucial.

Purpose of the Study:

• To evaluate the tolerance and physiological response to autologous blood donation in elderly patients.
• To compare the outcomes of autologous blood donation in elderly donors versus a younger control group.
• To identify any adverse effects related to circulatory response post-donation.

Main Methods:

• 38 patients aged 66-75 years underwent weekly autologous blood donation with daily iron supplementation (200 mg).
• A control group of younger donors (18-65 years) was included for comparison.
• Parameters monitored included blood pressure, pulse, hemoglobin concentration, and 24-hour circulatory response.
• Patients with ASA criteria II or less were included.

Main Results:

• No statistically significant differences in blood pressure or pulse were observed between the elderly and younger donor groups.
• Hemoglobin reduction was comparable between groups, with a mean reduction of 1.1-1.2 g/dL across donations.
• None of the 38 elderly patients experienced negative circulatory side effects within 24 hours post-donation.

Conclusions:

• Autologous blood donation is well-tolerated by patients aged 66-75 years.
• Elderly donors exhibit similar physiological responses and tolerance levels to younger donors.
• This practice can be safely implemented in older adult populations without significant adverse circulatory effects.